6-AMINO-4,5-DIHYDRO-8H-1-(2-DISODIOPHOSPHONYLMETHOXYETHYL)-IMIDAZO-[4,5-E]-[1,3]-DIAZEPINE-4,8-DIONE
Compound with spectra: 1 NMR
![6-AMINO-4,5-DIHYDRO-8H-1-(2-DISODIOPHOSPHONYLMETHOXYETHYL)-IMIDAZO-[4,5-E]-[1,3]-DIAZEPINE-4,8-DIONE](/api/compound/5uSZ7Ngl6GD.png?ph=true&h=300&w=458 "6-AMINO-4,5-DIHYDRO-8H-1-(2-DISODIOPHOSPHONYLMETHOXYETHYL)-IMIDAZO-[4,5-E]-[1,3]-DIAZEPINE-4,8-DIONE")
| SpectraBase Compound ID | 5uSZ7Ngl6GD |
|---|---|
| InChI | InChI=1S/C9H12N5O6P.2Na/c10-9-12-7(15)5-6(8(16)13-9)14(3-11-5)1-2-20-4-21(17,18)19;;/h3H,1-2,4H2,(H2,17,18,19)(H3,10,12,13,15,16);;/q;2*+1/p-2 |
| InChIKey | GJPPVLOZICANNU-UHFFFAOYSA-L |
| Mol Weight | 361.16130056 g/mol |
| Molecular Formula | C9H10N5Na2O6P |
| Exact Mass | 361.016409 g/mol |
| Parent InChIKey | JCGMLVMDXOSEQL-UHFFFAOYSA-L |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6:DMSO |
6-AMINO-4,5-DIHYDRO-8H-1-(2-PHOSPHONYLMETHOXYETHYL)-IMIDAZO-[4,5-E]-[1,3]-DIAZEPINE-4,8-DIONE
methyl 4-[(benzylamino)carbonyl]-1-(2-hydroxy-3-phenoxypropyl)-1H-imidazole-5-carboxylate
N(9)-Cyclobutyl-N(2)-isobutyrylguanine
3H-imidazo[4,5-c]pyridine-4,6(5H,7H)-dione, 7-amino-3-[2-(dimethylamino)ethyl]-
9-[(3-BUTYRYLOXY-1-HYDROXY-2-PROPOXY)-METHYL]-2-BUTYRYLAMINOGUANINE
methyl 8-oxo-6-(phenoxymethyl)-5,6-dihydro-8H-imidazo[5,1-c][1,4]oxazine-1-carboxylate
9-[(1-HYDROXY-3-PROPIONYLOXY-2-PROPOXY)-METHYL]-2-PROPIONYLAMINOGUANINE
N-(4-ethoxyphenyl)-2-{[4-ethyl-5-(2-methoxyphenyl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetamide
9-[2-(p-bromophenoxy)ethyl]-1-methylisoguanine
5-amino-1-[2-(2-ethoxyanilino)-2-oxoethyl]-N-(2-ethylphenyl)-1H-1,2,3-triazole-4-carboxamide
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis of a novel ring-expanded (“fat”) nucleotide analogue of phosphonomethoxyethylguanine (PMEG) containing the imidazo[4,5-e][1,3]diazepine ring system | Journal of Heterocyclic Chemistry | 2001 |